News

ProDesign Adds New Shapes and Colours to Essential Collection

ProDesign Denmark has added four shapes in six colours each in the Essential Collection (models 1748-1751).

Read More

ZEISS DriveSafe Launching August 3, 2015

Launching August 3, 2015: A new solution from ZEISS to combat visual challenges when driving.

Read More

Aspex Eyewear Extends Greg Norman License Through 2025

Aspex Eyewear Group, based in Mont-Royal, Quebec, and Great White Shark Enterprises, the company founded by golfing legend Greg Norman, announced on July 27 that they have renewed the licensing agreement for Greg Norman Eyewear through 2025.

Read More

Essilor of America to Acquire Vision Source US

Vision Source Canadian assets not part of the transaction. Deal to close within a couple of months.

Read More

Renowned Vision Researcher Brien Holden Passes Away

Brien Holden, CEO and founder of the non-profit Brien Holden Vision Institute based in Sydney, Australia, passed away on July 27 at the age of 73.

Read More

Zeiss Canada Introduces ReLEx SMILE Flapless Laser Treatment

The most minimally invasive technique with femtosecond laser for the correction of refractive errors and sets another milestone in corneal refractive surgery

Read More

Transitions Announces Availability of New Poster and Patient Brochure

Transitions Optical, Inc. has released new point-of-purchase materials for 2015.

Read More

Kodak Unique HD Digitally Customized Progressive Lenses Now Available in Canada

Centennial Optical and Riverside Opticalab are pleased to introduce Kodak Unique HD digitally customized progressive lenses in Canada.

Read More

Tura Signs Eyewear License with Gwen Stefani’s L.A.M.B and GX Brands

Tura Inc. has announced a multi-year agreement with Grammy Award-Winning musician and fashion entrepreneur Gwen Stefani to introduce a new line of sunglasses and optical eyewear for her L.A.M.B. and GX by Gwen Stefani brands.

Read More

Unilens Vision Inc. Announces Agreement with Valeant Pharmaceuticals

Unilens Vision Inc, based in Largo, FL, announced they have entered into an agreement with a subsidiary of Valeant Pharmaceuticals, for the acquisition of all common stock at a value of $28 million.

Read More